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Abstract. We present a full-scale clinical prototype system for in vivo range verification
of proton pencil-beams using the prompt gamma-ray spectroscopy method. The detection
system consists of eight LaBr3 scintillators and a tungsten collimator, mounted on a rotating
frame. Custom electronics and calibration algorithms have been developed for the measurement
of energy- and time-resolved gamma-ray spectra during proton irradiation at a clinical dose
rate. Using experimentally determined nuclear reaction cross sections and a GPU-accelerated
Monte Carlo simulation, a detailed model of the expected gamma-ray emissions is created for
each individual pencil-beam. The absolute range of the proton pencil-beams is determined by
minimizing the discrepancy between the measurement and this model, leaving the absolute
range of the beam and the elemental concentrations of the irradiated matter as free parameters.
The system was characterized in a clinical-like situation by irradiating different phantoms with
a scanning pencil-beam. A dose of 0.9 Gy was delivered to a 5×10×10 cm3 target with a
beam current of 2 nA incident on the phantom. Different range shifters and materials were used
to test the robustness of the verification method and to calculate the accuracy of the detected
range. The absolute proton range was determined for each spot of the distal energy layer with a
mean statistical precision of 1.1 mm at a 95% confidence level and a mean systematic deviation
of 0.5 mm, when aggregating pencil-beam spots within a cylindrical region of 10 mm radius
and 10 mm depth. Small range errors that we introduced were successfully detected and even
large differences in the elemental composition do not affect the range verification accuracy.
These results show that our system is suitable for range verification during patient treatments in
our upcoming clinical study.
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1. Introduction
The advantageous depth-dose deposition profile of protons cannot yet be fully utilized in
clinical practice because of uncertainty in the beam range within the patient. The origin of
this uncertainty is the determination of the stopping power of tissue along the beam path,
which is affected by the CT imaging, the degeneracy in the conversion from x-ray attenuation
to stopping power, and the uncertainty in the ionization potential of human tissue (Andreo
2009). Furthermore, interfractional and intrafractional patient positioning errors and anatomical
changes can affect the range. Conservative safety margins (Albertini et al. 2011) and robust
treatment planning (Unkelbach et al. 2007) are currently required to ensure a complete tumor
coverage.
Efforts are being undertaken to reduce proton range uncertainty and the required safety
margins by performing an in vivo verification of the range during patient treatment. Several
methods have been suggested (Knopf et al. 2013), but no solution is available for routine
clinical use. The use of prompt gamma-rays, which originate from proton-nuclear interactions
with tissue, was proposed by Jongen et al. (2003) and is being actively investigated by various
groups (Krimmer et al. 2018). The virtually instantaneous emission of the gamma-rays, with a
time scale smaller than 10−11 s, enables real-time range verification of the delivered proton
pencil-beams. Through the high gamma-ray energy of typically several MeV, most of them
escape the patient and can be detected externally. For a successful clinical application, a
detection system has to meet several requirements. It needs to detect a sufficient number
of gamma-rays during a fractionated clinical treatment with fields that deliver a dose on the
order of 1Gy to the tumor, such that the range can be determined with millimeter precision.
The correlation of the measured gamma-ray emissions with the proton dose deposition needs
to be accurately known to minimize systematic bias. Determining this correlation based on
first principles requires extensive modeling of the nuclear reactions (Verburg et al. 2014), but
more empirical methods are also being investigated (Schumann et al. 2016). To not extend the
duration of the treatments, the detection needs to be performed while the protons are delivered
at a standard clinical beam current of about 2 nA incident on the patient. Under these conditions
and with a sufficiently efficient system, a detector load of millions of gamma-rays per second
is expected. The detection system also needs to function stably under the highly variable
count rates that occur during proton pencil-beam delivery. These are certainly challenging
requirements.
Individual prompt gamma-rays can be detected with scintillation detectors (Seo et al.
2006; Smeets et al. 2012; Pinto et al. 2014; Krimmer et al. 2017; Pausch et al. 2016; Verburg
et al. 2013), which need to be dense and thick to absorb the full energy. A form of collimation
is needed to reconstruct the spatial origin of the emission. Collimation is only needed along the
depth dimension, because the lateral position of each incident pencil-beam is monitored with
an ionization chamber in the beam line. A physical collimator made of a high-Z material, with
one or multiple slits perpendicular to the proton beam direction, limits the longitudinal position
along the beam path from where the detected gamma-rays originate. Another advantage of a
physical collimator is the shielding of gamma-rays emitted in the beam entrance path, which
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do not provide valuable information about the proton range. Alternatively, the transit time of
the protons in tissue until the prompt gamma-ray is emitted can be used as a form of virtual
collimation (Golnik et al. 2014; Hueso-Gonza´lez et al. 2015). Such time-based collimation
reduces weight and adds geometric flexibility. However, because of the time spread of the
incident protons in a bunch from a clinical proton acceleration system (Petzoldt et al. 2016), the
origin of the gamma-ray emission is less well defined than for passive collimation. It also adds
uncertainty because of the need to correlate the proton transit time with a spatial location in the
patient. Finally, the application of Compton cameras is being investigated (Hueso-Gonza´lez
et al. 2017; Solevi et al. 2016; Aldawood et al. 2017; Rohling et al. 2017; Draeger et al. 2018).
These systems do not require physical collimation either, but rely on the detection of multiple
Compton scatter interactions per incident gamma-ray in order to reconstruct its origin region.
Prompt gamma-ray imaging is an indirect range verification method that exploits the
correlation of the nuclear reaction positions with the deposited dose. Nuclear interactions
between accelerated protons and the nuclei of human tissue are complex processes. Numerous
nuclear reaction channels of protons with the main nuclei of tissue, 12C and 16O, exist. The
residual nuclei de-excite through the emission of gamma-rays with different discrete energies.
The patient-specific emissions of prompt gamma-rays during the treatment can be modeled
based on the CT scan, the treatment plan and nuclear physics models. Matching this model
with the measured prompt gamma-ray distribution provides a means to verify the ranges of the
proton pencil-beams.
In this context, it is important to define the goal of the range verification method. One
approach is to detect a deviation in the beam range through the comparison of measurements
from different treatment days. Such a detection would be clinically useful for quality assurance,
to verify the consistency among the delivered fractions. However, this approach does not
provide an estimate of the absolute proton range. Reducing the initial range margins, which is
our goal, imposes a more difficult requirement on the range verification. It requires an accurate
and robust determination of the absolute range of the beam with only the treatment plan as
prior knowledge.
Recently, initial studies of prompt gamma-ray detection during patient treatments with
passively scattered protons (Richter et al. 2016) and actively scanned proton pencil-beams (Xie
et al. 2017) were performed with a scintillation detector array combined with a knife-edge slit
collimator. Xie et al. (2017) measured the integral number of prompt gamma-rays during the
pencil-beam delivery. The median statistical precision of the range verification for a set of
distal layers was ±12 mm at 95% confidence (2σ ) for individual pencil-beams, and ±4.2 mm
after aggregating pencil-beams laterally within the same layer with a Gaussian kernel with a 7
mm standard deviation. The positioning accuracy of the setup was estimated as ±1.5 mm at
2σ (Xie et al. 2017). The bias in the absolute range from sources other than positioning was
not discussed. In the case of Compton cameras, relative range shifts of a few millimeters are
theorized to be detectable with larger scale Compton camera systems (Draeger et al. 2018),
which have not been constructed yet.
For several years, we have been developing a proton range verification method that is
uniquely based on prompt gamma-ray spectroscopy (Verburg et al. 2013; Verburg et al. 2012;
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Verburg et al. 2014). This method uses both the arrival time and energy of the detected prompt
gamma-rays. Using a small-scale prototype, we first showed energy- and time-resolved prompt
gamma-ray spectra that were measured during the delivery of proton beams (Verburg et al.
2013). We use detailed models of the nuclear reactions associated with the discrete prompt
gamma-ray emissions to verify the absolute range of proton beams in phantoms, without
requiring prior knowledge of the elemental composition of the irradiated matter (Verburg et al.
2014). Moreover, the measurement of the arrival time of the gamma-rays allows a separation
of proton- and neutron-induced gamma-rays, which removes the confounding uncertainty from
the neutron-induced gamma radiation background in the treatment room.
In this paper, we describe the development and evaluation of a new full-scale clinical
prototype detection system for proton range verification based on prompt gamma-ray
spectroscopy. This system will be deployed for the first clinical study with patients. We
present the detectors, collimator and data processing methods in section §2. Section §3
describes a fully integrated clinical workflow for modeling the prompt gamma-ray emissions
based on the treatment plan, in order to predict the number of gamma-rays detected when
different range errors occur, and to verify the proton range by comparing the measurements
with the model. The experimental setups that we use to optimize the cross section data and
to evaluate the range verification performance of the system are shown in section §4. The
results of the experiments are given in section §5, in which we assess the detector performance
and the accuracy and statistical precision of the proton range verification. In section §6, we
discuss the obtained results and the consequences for the clinical implementation, and the main
conclusions of the study are drawn in section §7.
2. Detectors and data processing
2.1. Proton beam
The experiments were performed in the pencil-beam scanning treatment gantry at the Francis H.
Burr Proton Therapy Center, Massachusetts General Hospital. Protons were accelerated to 230
MeV with an IBA C230 cyclotron (Ion Beam Applications SA, Louvain-la-Neuve, Belgium),
degraded by an energy selection system, and transported to the treatment room along a beam
line with a length of approximately 35 meters. The cyclotron features a radiofrequency of
106.3 MHz. All pencil-beam layers were delivered with the standard clinical system at the full
beam current of 2 nA incident on the phantom, which corresponds to a bunch of approximately
100 protons every 9.4 ns. Based on routine quality assurance measurements, the reproducibility
of the beam range in water is known to be better than 0.5 mm.
2.2. Detectors and collimator
Gamma-rays are detected using eight detector modules, each consisting of a cerium-doped
lanthanum(III) bromide scintillation crystal (Saint-Gobain, Saint Pierre Le`s Nemours, France)
with a diameter of 50.8 mm and a length of 76.2 mm, a photomultiplier tube, and a custom
base with a Cockcroft–Walton high voltage generator and a transistorized voltage divider. The
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Figure 1: Left: 3D model of the clinical prototype system, which can rotate around its axis according
to the beam incidence angle. The tungsten collimator is visible on the front plane, the eight scintillation
detectors in the middle and the readout electronics on the back plate. Right: photo of the system in the
gantry treatment room. The red arrow shows the proton beam incidence direction.
total volume of scintillation material is 1236 cm3. The detector signals from the anode of
the photomultipliers are amplified with transimpedance amplifiers that are located next to the
detectors. The scintillators and electronics are designed to sustain high overall event rates of
up to 107 events per second.
The gamma-rays in the entrance path of the beam are shielded by a 127 mm thick and 102
mm wide block of tungsten. Along the beam direction, this is followed by a slit opening of 12.7
mm and a single collimator slab with a width of 25.4 mm. Four detectors are stacked with their
center aligned with the edge of the proximal collimator. The other four detector modules are
located distal of these detectors in a closely packed configuration (see figure 1). Each row of
detectors therefore focuses on a different position along the beam direction. Because many of
the prompt gamma-rays interact through Compton scattering or pair production, the volume of
scintillation material that is not directly in view of the primary prompt gamma-rays contributes
to the probability of the absorption of the full photon energy.
2.3. Data acquisition system
The detectors are connected to a custom data acquisition system located in the treatment
control room. This system is synchronized with the pencil-beam delivery system and the
cyclotron. The signals from the eight detector modules are independently read out with a
14-bit analog-to-digital converter that is phase-locked to the accelerator at a frequency of
twice the cyclotron radiofrequency, resulting in a sample rate of approximately 2.13× 108
samples per second. The data from the analog-to-digital converters are processed in real-time
by field-programmable-gate arrays (FPGAs). A trigger to acquire an event is generated when
the digitized signal magnitude exceeds a predefined threshold.
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The gamma-ray energy is calculated by integrating the area under the pulse signal over a
time window of 200 ns. The pulse shape is used to determine whether the gamma-ray event is a
single gamma-ray detection or a pile-up of several gamma-rays (section §2.6). The calculations
and the storage in memory result in a dead-time of 150 ns after each event, during which
the individual detector module is not sensitive to a new event. Because of the fast detectors
and the short dead-time, the average separation time between two gamma-ray events is much
longer than the time required to acquire an event. We can typically acquire about 90% of the
gamma-rays that interact with the detectors and deposit an energy within the range of interest.
To find the precise arrival time of the gamma-ray, we subtract a delayed copy of the digital
signal from the original one and find the zero crossing time of the resulting signal. This time
point is independent of the signal magnitude. The arrival time analysis is first performed with
a time resolution equal to the sample rate. Subsequently, we use a polynomial interpolation to
achieve sub-nanosecond resolution.
A second data acquisition board performs real-time acquisition of the pencil-beam delivery
status and the signals from the beam monitoring electronics. It also enables the detector readout
only during the beam-on periods. The clock of this board is synchronized with the detector
readout board, therefore providing the exact beam status of the pencil-beam delivery for each
detected gamma-ray.
The acquired data are stored in a memory buffer that is continuously read out by the control
software, which is a custom C++ application on a Linux system. This application provides
a real-time graphical display of the acquired data and the beam status. An important task of
this software is to perform various corrections to normalize all measurements to absolute units,
independently of conditions such as the detector load and the neutron-induced background, as
will be discussed in the next sections.
2.4. Energy calibration
Although the detector readout electronics are designed for high stability at various detector
count rates, a small dependency of the signal amplitude as a function of the count rate is
unavoidable. Moreover, any scintillator has some temperature dependence. To make the
measurements independent of these factors, an automated energy calibration as a function of
the detector count rate is implemented. After applying the initial fixed calibration factor, an
energy correction function is determined for each proton energy layer using the gamma-rays
from neutron capture by hydrogen at 2.22 MeV, which are very abundant in every measurement.
A 2D histogram with the uncorrected line energy as a function of the pencil-beams ordered
by count rate is created. A 2D curve is fitted, namely a normal distribution in the energy
dimension with a shifting mean value, which is linearly correlated to the ordered pencil-beam
number. The benefit of simultaneously considering all pencil-beams within a layer is that
statistical variations have negligible impact. The ratio between the uncorrected energy at the
peak position and the actual gamma-ray energy of the neutron-hydrogen line is applied as a
small correction on the order of 1%.
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A very small non-linearity is also present in the correlation of the signal amplitude with
energy. The correction for this effect is also automated and is the same for all pencil-beams.
This correction is performed by analyzing the spectral position of a few strong gamma-ray
lines with known energies and fitting a polynomial correction function, which is then applied
to all measurements.
2.5. Time calibration
The gamma-ray arrival time relative to the cyclotron radiofrequency period is different for
each energy layer because of the different flight times of the protons through the beam lines.
For each detector and spot, we automatically center the proton-induced prompt gamma-ray
peak in the time dimension. Due to space charge effects in the photomultiplier, the shape of
the detector signals slightly depends on the energy. To remove any energy dependency in the
arrival time, a correction is applied by finding the location of the proton-induced peak in the
time dimension for several energy regions and by performing a linear fit. This is similar to the
method described by Hueso-Gonza´lez et al. (2014).
2.6. Pile-up rejection
Piled-up events, where multiple gamma-rays interact with the detector at almost the same time
such that they can not be separated, are detected using pulse shape analysis. A set of expected
pulse shape parameters and their variance were obtained from a laboratory measurement at a
very low event rate. Whenever one parameter is outside the expected nominal window, i.e.,
the regular pulse shape, the event is marked as a piled-up event and discarded from further
analysis. The acceptance window is calibrated for each detector separately to account for the
slight differences in pulse shape between detectors.
A small fraction of the piled-up events cannot be detected by this method. This can happen
if two events are very close to each other in time (T1 = 15ns) so that the sum of pulse shapes
is similar to a single one, independently of their respective energies; or if the second event
arrives within T2 = 150ns, but has a small energy with respect to the previous one, so that the
pulse shape difference is not significant. Consequently, events with a wrong energy or time
stamp are included in the analysis as valid events, but contribute to the background rather than
to resolved lines. A correction scale factor S is applied depending on the detector count rate R:
S = exp[R( f1×T1+ f2×T2)], (1)
in which f1 and f2 are empirically determined parameters for the two aforementioned effects
and T1 and T2 are the corresponding time constants. The values of these parameters are
determined such that the magnitude of the proton-induced gamma-rays acquired in a fixed time
period is proportional to the proton beam current.
2.7. True number of events
The number of valid events NE during the delivery of a pencil-beam is lower than the true
number of events NT because of the dead-time and pile-up of two or more gamma-rays. To
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determine the true number of events, we take advantage of the fact that Poisson statistics apply
to the occurrence of the events. This assumption is valid if the dose rate is constant, which
is a good approximation because the duration of the pencil-beam delivery is much longer
than the duration of the ramp-up and ramp-down processes. As described by Be´cares et al.
(2012), Poisson statistics imply that the separation times between consecutive events feature an
exponential distribution. We fit the measured separation time distribution for times that exceed
the pulse duration and dead-time. The true number of events is then given by the integral of the
fitted distribution, including also the virtual events with a short separation time that precluded
them from being acquired. The correction is applied as a scaling factor D = NT/NE equal to
the ratio between true and acquired events.
2.8. Coincidence rejection
When analyzing discrete gamma-ray lines, it is desirable to reject events in which Compton
scatter occurred in the scintillator. In these events, the full energy of the gamma-ray was
not absorbed in a single detector and therefore the event contributes only to the continuum
background. If the scattered gamma-ray interacts with a second detector, we are able to reject
such events through the analysis of coincidences between the detectors. If events in separate
detectors are separated in time by less than 3 ns, both events are rejected.
There is a small probability of erroneously rejecting events that are not due to Compton
scatter. This is corrected for each pencil-beam by using a random coincidence correction,
based on a histogram of the time difference between consecutive events in different detectors.
It is expected to present a baseline plus a peak of true coincidences around zero. The total
number of coincidences NC is the integral of the histogram within the coincidence window.
The number of random coincidences NR is determined by fitting the baseline of the histogram
with a quadratic curve and calculating its integral within the aforementioned window. The
random coincidence correction C is calculated as:
C = 1+
1/NE
1/NR−1/NC . (2)
2.9. Histogram analysis
The fully corrected data are combined in 2D histograms with dimensions of energy and time
(Verburg et al. 2013). We create two histograms for each proton pencil-beam: one for each row
of four detectors, see figure 1. An iterative method is used to split the measured 2D histograms
into three different components:
Proton-induced continuum. Prompt gamma-rays that undergo incoherent scattering in the
detector, or that have scattered before reaching the detector, contribute to an unresolved
background in the energy dimension, but are well resolved in the time dimension. A
second contribution to the unresolved continuum is from a quasi-continuum of discrete
gamma-rays from the cascade decay of higher excited states (Capote et al. 2009), which
cannot be resolved as separate lines.
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Neutron-induced continuum. Like the proton-induced continuum, the neutron-induced
gamma-rays can also scatter before or inside the detector, or stem from unresolved
cascades. This structure is both unresolved in time and energy.
Resolved lines. Subtracting the continuum components results in a histogram with only
resolved lines. They correspond to prompt gamma-rays that either deposit the full energy
in one of the detectors, or the full energy minus one or two 511 keV escape photons. These
peaks are resolved in both the energy and time dimension. In addition, neutron-induced
reactions such as the neutron capture of hydrogen result in lines that are resolved in energy
but not strongly resolved in time.
A robust separation of these three components is crucial, because it allows a direct comparison
of the measurements with fundamental physics models. The discrete proton-induced gamma-
ray lines can be fully modeled based on nuclear reaction cross sections, and their quantification
also carries the essential information about the elemental concentrations in the irradiated tissue.
For a spot-wise 2D separation of proton- and neutron-induced events, a dedicated algorithm
was designed: the Recursive Bisection Neutron Subtraction (ReBiNS). First, a time projection
of the 2D histogram is obtained for all energy bins. The neutron background is estimated on
the resulting 1D time spectrum M(t) by means of the SNIP algorithm (Ryan et al. 1988). The
proton-induced histogram is obtained by subtracting the neutron background from the original
histogram M(t). Both the neutron-induced and proton-induced 1D histograms are normalized
and fitted by cubic splines, serving as numeric probability density functions of the neutron
sn(t) and proton sp(t) time structures. Then, the time spectrum M(t) is fitted to
M(t) = N× sn(t)+P× sp(t), (3)
where N is the number of neutron-induced counts, P the number of proton-induced counts,
and N+P is constrained to the total number of histogram entries T in M. Once the parameters
are calculated, a similar fit is done for each energy bin individually. To ensure the robustness
and consistency with the global fit, a recursive bisection strategy is applied. First, two time
projections a and b are created among the upper and lower half of the 2D energy-over-time
spectrum. Then, a simultaneous fit of equation (3) is done on both projections, but with
fixed shapes sn(t), sp(t) and the cross-constraints Na +Nb = N, Pa +Pb = P, Na +Pa = Ta,
Nb+Pb = Tb. Each of the regions is again divided in two sub-regions, and the procedure is
repeated recursively until the sub-regions consist of single energy bins i. The set of fitted
parameters Ni and Pi can be interpreted as an energy spectrum of the neutron-induced and
proton-induced contributions. Both 1D spectra are further analyzed to separate the continuum
background from the resolved lines by means of the SNIP algorithm.
The magnitude of the gamma-ray lines is determined by a 2D fit of the resolved line
histogram. The peaks are modeled as Gaussians in the energy dimension and as sp(t) in the
time dimension, or sn(t) in the case of resolved neutron-induced lines.
2.10. Lateral spot merging
For range verification, we create histograms in which the data of neighboring pencil-beams
within the same energy layer are summed if their center position is within a 10 mm lateral
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Table 1: Indices used within the prompt gamma-ray emission and detection model.
Index Bins Step Min. Max. Description
v # voxels 1 0 # voxels voxel of the field of view (120×160×160)
p # pixels 1 0 # pixels pixel of the front plane (120×160)
e 150 1 MeV 0 MeV 150 MeV proton kinetic energy within the field of view
s # spots 1 0 # spots spot of the treatment plan
l 7 1 0 6 prompt gamma-ray line (0: 1.6 MeV, 1: 2.0
MeV, 2: 2.3 MeV, 3: 2.8 MeV, 4: 4.4 MeV, 5:
5.2 MeV, 6: 6.1 MeV)
t 2 1 0 1 target nucleus (0: oxygen 16O, 1: carbon 12C)
θ 360 0.25° 0° 90° polar angle
φ 360 1.00° 0° 360° azimuthal angle
a 5 1 0 4 absorption process: (0) full, (1) single and (2)
double escape, (3): any energy deposit
between 1.4 MeV and 3.0 MeV, or (4): higher
than 3.0 MeV.
d 8 1 0 7 scintillation detector
r 2 1 0 1 row of detectors (0 : ∑3d=0, 1 : ∑
7
d=4)
c 17 1 0 16 discrete range error scenario in steps of 1 mm
(c = 8→nominal scenario)
radius of the spot under consideration. With our beam delivery system, this usually results
in data from seven pencil-beams to be accumulated. Based on Poisson statistics, one would
theoretically expect this to yield an improvement of the statistical precision by a factor of
2.6, at the expense of a reduction in spatial resolution. Note that considerable overlap already
exists between neighboring pencil-beams near the end-of-range because of multiple Coulomb
scattering.
3. Range verification method
A sophisticated simulation of the fundamental physical processes like nuclear interactions,
attenuation and detector system response was developed to accurately predict the prompt
gamma-ray emissions and detections. This model is compared to the measurement data to
determine the proton range for each pencil-beam.
The model is split up into several parts: geometry definition, CT to material conversion,
proton stopping process, prompt gamma-ray emission, gamma-ray attenuation, and detection.
An overview of the indices and parameters defined in subsequent sections is presented in
tables 1 and 2, and a graphical workflow is shown in figure 2.
3.1. Field of view
A volume of 12 cm in the direction parallel to the proton beam path (x axis), 32 cm in the
direction perpendicular to the pencil-beams pointing towards the detector system (z axis) and
32 cm in the third dimension (y axis) is defined as the field of view (FOV) of the detector, see
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Table 2: Parameters used within the prompt gamma-ray emission and detection model.
Parameter Description Source
mv material composition in voxel v. CT, Schneider et al.
(2000)
µvl attenuation coefficient in voxel v in cm-1 for a γ-ray with
energy l.
m, XCOM Berger
et al. 2010
ρvt concentration by mass of target t in voxel v in g/cm3. ρˆvt :
expected, ρvt : optimized.
CT
Ncsvep protons in voxel v with energy e for spot s and range error
scenario c.
GPU
σ elt differential cross section at 90 degrees of a proton with
energy e reacting with target t and emitting a prompt γ-ray
with energy l. σˆ elt : expected, σ elt : optimized.
Verburg et al. (2014)
ψeta effective cross section accounting for all prompt γ-rays
from unresolved energy levels l > 6 at target t for
absorption processes a = 3,4 and proton energy e.
Experiment
Ncsvltγ prompt γ-rays of transition l of nucleus t emitted in voxel v
for spot s and range error scenario c.
Npρσ
τvlθφ probability that a prompt γ-ray with energy l emitted in
voxel v in direction (θ ,φ) reaches the front plane z = 160
mm without interaction.
µ , ray tracing
η pθφ lda probability that a prompt γ-ray with energy l crossing the
pixel p of front plane z = 160 mm at an angle (θ ,φ)
undergoes absorption process a in detector d.
TOPAS Perl et al.
2012
ξ vlda probability that a prompt γ-ray with energy l emitted in
voxel v reaches the front plane without undergoing any
interaction and then undergoes absorption process a in
detector d.
ητ
ζ csltdaγ expected number of prompt γ-rays undergoing absorption
process a in detector d, that were emitted from target
nucleus t and from transition l for spot s and range error
scenario c.
Nγξ
Cslraγ measured γ-rays from transition l, absorption process a for
spot s and detector row r.
Experiment
kst elemental concentration correction factor (ρ = kρˆ) for
target t and spot s.
Experiment, Fit
εs absolute range error for spot s, namely the difference
between the optimized and the planned range
ε = (c−8)× (1mm).
Experiment, Fit
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Figure 2: Simplified workflow chart visualizing the prompt gamma-ray detection model generation
based on the CT scan of the patient, the treatment plan, the detector geometry, the tabulated nuclear
cross sections and the XCOM database. GPU and TOPAS Monte Carlo simulations, as well as analytical
ray tracing are performed. The mathematical symbols are described in table 2.
figure 3. This volume is discretized into voxels of 1×2×2mm3 to define a grid on which the
simulation is performed. The voxel size in the dimension parallel to the beam path is set to the
smallest distance of 1 mm, since this axis corresponds to the direction along which the range
verification is performed. The FOV therefore consists of 120×160×160 voxels. We define
the front plane of the FOV at the surface z = 160 mm, which is divided in 120×160 pixels, as
seen in figure 3.
3.2. CT scan and material conversion
As the first step of the model simulation, the CT numbers of the patient or phantom scan are
interpolated onto the FOV grid. Based on standard conversion schemes, the following data are
estimated for each voxel v: the material composition mv, the mass concentration ρˆvt of oxygen
and carbon, and the attenuation coefficient µvl that depends on the gamma-ray line energy l.
The material composition and density conversions needed for the simulation are retrieved from
the CT scan using the conversion scheme of Schneider et al. 2000, whereas the attenuation
coefficients are extracted from the XCOM database (Berger et al. 2010). These will be the
input data for the next simulation steps. Note that the model relies to some extent on prior
information of the initial CT scan, but can later be adjusted by leaving the oxygen and carbon
concentrations as free parameters ρvt . The reason for focusing on those two elements is that
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Figure 3: Sketch of the detector FOV from the perspective of the beam (a) and of an observer behind
the detector (b). The collimator slabs (gray) and the eight detectors (green) are overlaid. A patient or
phantom (blue) is shown as an example, that could be located anywhere within the FOV. The x axis is
parallel to the beam axis (red), the y axis is parallel to the slit, and the z axis completes the right-handed
triad, pointing towards the detectors. The x axis origin is on the center of the standalone collimator slab
at a distance |x0| from the upstream edge of the phantom or patient, whereas the y axis is centered on
the proximal collimator block. The z axis origin is at 160 mm normal to the front plane (orange line)
of the collimator and at a lateral distance |ziso| of the central beam axis. The FOV covers a region of
120×320×320mm3.
they are the most abundant nuclear targets for prompt gamma-ray emission in human tissue
(Verburg et al. 2012). Other elements have a minor contribution to the proton-induced signal,
or none in the case of hydrogen.
3.3. Proton energy spectrum
The stopping of the pencil-beams within the patient or phantom is modeled using an extended
version of gPMC (Jia et al. 2012; Qin et al. 2016), which is a CUDA GPU-accelerated Monte
Carlo code specifically designed for proton therapy simulation. The simulations are performed
on a Tesla K40 GPU accelerator (NVIDIA Corporation, Santa Clara, CA). The Monte Carlo
beam model has been calibrated to match experimentally measured Bragg peaks following the
method of Verburg et al. (2016). Through the use of the Monte Carlo method, geometries with
complex tissue inhomogeneities, range straggling and strong multiple Coulomb scattering are
modeled accurately.
To quantify the absolute proton range, we simulate several range error scenarios c in steps
of 1 mm. The range of the protons in the GPU Monte Carlo simulation is altered by slightly
changing the incident proton energy. We have automated the Monte Carlo simulation based on
the treatment plan, the converted densities ρˆvt and material compositions mv. The output of the
simulation is the deposited dose and the proton energy spectrum, i.e., the number of protons
Ncsvep with kinetic energy e in each FOV voxel v for every pencil-beam spot s and range error
scenario c.
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Table 3: Nuclear reaction channels leading to abundant prompt gamma-ray emission in human tissue
(Verburg et al. 2014), classified according to the oxygen and carbon target nuclei. The index l
corresponds to that of table 1 and the energies of the prompt gamma-rays are given in MeV. Reactions
which result in the emission of prompt gamma-rays with similar energies are clustered at the same index
l as they cannot be resolved experimentally.
Index l γ energies / MeV Reactions with 16O Reactions with 12C
0 1.63 16O(p,xγ) 14N
1 2.00 16O(p,xγ) 11C 12C(p,xγ) 11C
2.04 16O(p,xγ) 15O
2 2.31 16O(p,xγ) 14N
3 2.74 16O(p, p′ γ) 16O
2.79 16O(p,xγ) 14N
2.80 16O(p,xγ) 11C 12C(p,xγ) 11C
2.87 16O(p,xγ) 10B 12C(p,xγ) 10B
4 4.44 16O(p,xγ) 12C 12C(p, p′ γ) 12C
4.45 16O(p,xγ) 11B 12C(p,xγ) 11B
5 5.24 16O(p,xγ) 15O
5.27 16O(p, p pγ) 15N
5.18 16O(p,xγ) 15O
5.30 16O(p, p pγ) 15N
6 6.13 16O(p, p′ γ) 16O
6.18 16O(p,xγ) 15O
3.4. Prompt gamma-ray emission
The next step involves the calculation of the number of prompt gamma-rays with discrete
energies l emitted along the beam path. We do not rely on a Monte Carlo simulation of the
nuclear reactions and gamma-ray emissions; only experimentally determined cross sections
are used. Besides the output data from the GPU Monte Carlo simulation Ncsvep and the target
nuclei concentrations ρˆvt from the CT scan, the differential cross sections σ elt of every prompt
gamma-ray transition l and target nucleus t are needed, which depend on the proton energy
e. For the determination of the number of prompt gamma-rays Ncsvltγ emitted along the beam
path for each pencil-beam s, range error scenario c, voxel v, transition l and target nucleus t,
the voxel-dependent proton energy distributions from the GPU Monte Carlo simulation are
multiplied with the energy-dependent cross sections and target concentrations:
Ncsvltγ =∑
e
Ncsvep ·
ρˆvtNA
At
·4piσ elt , (4)
where At is the molar atomic mass of target element t and NA is the Avogadro constant. The
lines included in the model are described in table 1, and correspond to the nuclear reaction
channels listed in table 3.
In addition, the proton continuum spectrum is considered, as it contains a significant
fraction of the collected events. This continuum is in part due to gamma-rays from the
main discrete lines that do not deposit their full energy in the detectors. Another part, which
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contributes approximately to an equal extent, is the prompt gamma-ray quasi-continuum. These
are emissions of unresolved gamma-rays N˜csvltaγ from unknown transitions l which are not
resolvable in the measurement. This part is approximated by a linear combination of known
lines with an effective cross section ψeta depending on the proton energy e, target t, and are
associated with absorption processes a = 3,4 (ψeta = 0 if a< 3):
N˜csvltaγ =∑
e
ulNcsvep ·
ρˆvtNA
At
·4piψeta, (5)
where the constants ul are normalized weights chosen such that the continuum gamma-ray
emission energy spectrum is approximately constant up to 6 MeV.
The proton energy range that we model for the prompt gamma-ray emission within the
detector FOV ranges from 0 to 150 MeV. The incident energy of the proton beam can be as
high as the maximum energy of 230 MeV, because the energy of the protons is reduced to well
below 150 MeV before they reach the FOV.
3.5. Gamma-ray attenuation
The calculation of the detection probability of the emitted gamma-rays is separated into two
parts: a measurement-specific calculation of the gamma-ray attenuation based on the CT scan
of the patient or phantom, and a model of the collimator-detector system that is the same for
all measurements, which is discussed in the next section.
We define the transmission probability τvlθφ for a gamma-ray with energy l traveling
from FOV voxel v to the detector in the direction with angles (θ ,φ) that reaches the detector
front plane without undergoing any interaction, see figure 3a. It is modeled using a ray tracing
algorithm (Amanatides et al. 1987) with the energy-dependent attenuation coefficients of the
FOV voxels µv′l calculated previously. The transmission probability is given by the sum along
the path `′ that connects voxel v with the crossing point on the front face plane, that is defined
by θ and φ :
τvlθφ = exp
(
−∑
v′
µv
′lδ`′
)
, (6)
where δ`′ is the intersection length of the path `′ within the voxel v′.
3.6. Collimator-detector system response
The detection probability η pθφ lda of the collimator-scintillator system is determined using a
Monte Carlo simulation of the electromagnetic interactions using the TOPAS Monte Carlo
code (Perl et al. 2012) with the Geant4 10.04.p01 toolkit (Allison et al. 2016). The positions,
dimensions and material compositions of all parts influencing the detection probability, i.e.,
the collimator and scintillation crystals, are included in the model. Photons with energies
corresponding to the prompt gamma-ray lines l are simulated, originating from the front plane
of the detection system, which is divided into pixels p as shown in figure 3b. The simulated
photons are emitted isotropically from all front plane positions and directions defined by
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angles θ and φ . Five types of events corresponding to different types of interactions a in the
detectors d are counted. Events in which the whole initial photon energy is deposited in a single
scintillation crystal (a= 0) are counted as full energy detection events, (1) single and (2) double
escape lines are simulated by counting the events where the deposited energy corresponds to
the initial photon energy reduced by 511 keV, respectively 1.022 MeV. Additionally, any event
with (3) a deposited energy between 1.4 MeV and 3.0 MeV or (4) a deposited energy higher
than 3.0 MeV is recorded.
The total detection probability ξ vlda for a gamma-ray of transition l originating from
voxel v, not interacting until reaching the front plane and undergoing an absorption type a in
detector d yields:
ξ vlda =∑
θ ,φ
τvlθφ ·η pθφ lda, (7)
where p is the pixel on the front plane that is intersected by the path from voxel v in the
direction (θ ,φ).
3.7. Absolute range verification
The expected counts ζ csltdaγ according to the simulated model are calculated for every range
error scenario c, pencil-beam spot s of the treatment plan, target nucleus t, prompt gamma-ray
line l, interaction type a and detector d:
ζ csltdaγ =∑
v
(
Ncsvltγ + N˜
csvlta
γ
)
·ξ vlda, (8)
and we sum over each detector row r:
ζ csltraγ =
4r+3
∑
d=4r
ζ csltdaγ . (9)
The results of the independent simulations with discrete range error scenarios c are
interpolated to get a continuous model of the counts (ζ csltraγ → ζ εsltraγ ) as a function of the
absolute range error ε = (cˇ−8)× (1mm), where cˇ is the interpolated counterpart of c.
The absolute proton range of a pencil-beam spot s is determined by minimizing the least
square residuals between the experimentally measured gamma-ray counts Cslraγ and the modeled
ones ζ εsltraγ , leaving the range error scenario c and actual target concentrations ρvt = kvt ρˆvt as
free parameters:
argmin
εs,ks0,ks1,χs3
(
∑
l,r,a
wa
∥∥∥∥χsa∑
t
kstζ ε
ssltra
γ −Cslraγ
∥∥∥∥2
2
)
. (10)
In total, for every spot, four parameters are fitted: εs,ks0,ks1,χs3. The correction factors
kv0 and kv1 of the target concentrations (ρvt = kvt ρˆvt) are assumed to be a constant multiplier
(kvt → kst) within the region of interest of the FOV of spot s. χsa is a multiplication factor that
is 1 if a < 3 and is left as free parameter for the continuum absorption processes (χs3=χs4).
This multiplier allows to account for small concentrations of other nuclei that are not modeled
in the continuum emission, as well as small errors that are introduced by the fact that the
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gamma-ray attenuation in the patient cannot be exactly modeled for the continuum component.
wa is an empirical scaling constant which is 1 for a < 3 and 0.1 otherwise, to equalize the
absolute contribution of each absorption process to the least squares.
The measurement of the proton continuum Cslr3γ and C
slr4
γ cannot be distinguished
experimentally depending on l. The experimental value corresponds to the sum of all lines,
and is redistributed among each line l according to the weights ul , and is compared then to the
values predicted by the simulation at absorption process a = 3 or a = 4 and line l.
The Levenberg–Marquardt algorithm was used to solve the optimization problem in
equation (10). For the present detector geometry, the problem is convex and the optimization
converges to the same global optimum independently of the initial values of the parameters.
3.8. Distal spot aggregation
Pencil-beam spots s˜ that are delivered to the same lateral position of spot s, but to an adjacent
energy layer with a proton range that differs by less than 10 mm, will be subject to almost
the same range error scenario εs ≈ ε s˜ and elemental concentration correction factors kst ≈ ks˜t ,
χsa ≈ χ s˜a. Instead of treating these spots as being fully independent, it is useful to determine
their range error simultaneously to improve statistical precision. This is accomplished by
simultaneously fitting the parameters for these spots, rather than by merging the histograms as
done in the lateral direction (section §2.10). Hence, for each spot s, we optimize:
argmin
εs,ks0,ks1,χs3
(
∑
s′
∑
l,r,a
wa
∥∥∥∥χsa∑
t
kstζ ε
ss′ltra
γ −Cs
′lra
γ
∥∥∥∥2
2
)
, (11)
where s′ is a set of spots including the pencil-beam s and the aggregated ones s˜. When verifying
the most distal energy layer, this normally results in only one spot s˜ from the second most
distal energy layer to be aggregated to the spot s under consideration.
3.9. Cross section optimization
The nuclear reaction cross sections σ elt for the prompt gamma-ray production are the
cornerstone of our model, which enable the absolute range verification based on fundamental
physical principles. We previously published the cross sections that we use for 16O and 12C
nuclei for a 90 degree angle between the incident beam and the detector (Verburg et al. 2014).
These are based on a combination of our own measurements and previous literature referenced
therein. Unlike other measurements that are typically performed at a few specific proton
energies, we optimized the cross sections for the complete proton energy range from 0 to
150 MeV, which is required for range verification of beams stopping in matter. The range
verification is not sensitive to small resonances in the cross sections because of the energy
spread of the proton beam close to the end-of-range.
As is typical for cross section measurements, these are subject to some systematic errors
due to issues such as the bias in the separation of the gamma-ray line from the background.
Because our present system features new data acquisition algorithms and improved methods
to separate the gamma-ray lines from the background, we have re-optimized our previous
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cross sections σ̂ elt by applying a small correction based on a reference measurement in water
and in high-density polyethylene. Because of the improvements, we expect the re-optimized
cross sections to have a smaller systematic error as compared to our previous optimization.
By using the same system for the cross section optimization and the range verification, this
re-optimization is also effectively a calibration that removes the effect of the system-specific
systematic bias.
To obtain the optimized cross sections σ elt , we minimize the discrepancy between the
measured gamma-ray counts Cslraγ and the values predicted by the model ζ csltraγ for the nominal
case c = 8 (0 mm range error) and each target t = 0,1, line l and proton energy e:
argmin
σ elt
(
2
∑
a=0
∑
s,r
∥∥∥kstζ 8sltraγ −Cslraγ ∥∥∥22+λ ∥∥∥σ elt− σˆ elt∥∥∥22
)
, (12)
where
ζ 8sltraγ =
4r+3
∑
d=4r
∑
e
N8svep ·
ρvtNA
At
·4pi
(
σ elt +ul ·ψeta
)
·ξ vlda (13)
and λ is an empirical damping factor. The first term is the least squares optimization between
the model and the measurement, while the second one is a Tikhonov regularization term to
penalize large differences between the reference cross sections σ̂ elt and the optimized ones
σ elt . Note that, in this calibration experiment, kst is fixed as the target composition is well
known.
Likewise, for the effective cross sections ψeta that describe the unresolved continuum, we
optimize for a = 3 and a = 4:
argmin
ψeta
(
∑
s,l,r
∥∥∥kstζ 8sltraγ −Cslraγ ∥∥∥22
)
. (14)
4. Experimental setups
4.1. Cross section optimization
The measurements for the cross section optimization were performed during the delivery of
a single high-dose spot (3× 1010 protons) along the central beam axis consecutively to 19
energy layers to either a water phantom or to a solid block of polyethylene. The phantom was
mounted on a linear stage on breadboard for accurate positioning. We estimate the positioning
uncertainty in depth to be ±0.5mm. The proton ranges were between 10 cm and 15 cm water
equivalent, corresponding to incident energies of 116 MeV to 145 MeV. In this setup, the
detector FOV (see figure 3) was centered at a depth of −x0 = 124mm in the phantom and the
distance between the isocenter and the front plane of the collimator was 150 mm (ziso = 10mm),
including an air gap of 100 mm.
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Table 4: Characteristics of the treatment plan designed for delivering 0.9 Gy dose uniformly to a
5.3×10×10cm3 target volume in water with a beam current of 2 nA, see figures 4 and 5, divided in
eight iso-energy layers. The reported proton range R80 is the physical distance from the phantom front
face.
Layer Proton energy Range R80 # spots # protons Protons / spot Dose to target
MeV mm ×109 ×109 (mean) Gy (mean)
0 176 210 203 24.1 0.12 0.25
1 173 203 217 29.1 0.13 0.32
2 168 194 199 12.8 0.06 0.13
3 164 186 180 8.2 0.05 0.08
4 160 178 180 7.7 0.04 0.06
5 156 171 167 6.3 0.04 0.04
6 152 163 127 4.0 0.03 0.02
7 148 155 137 5.7 0.04 0.02
Total 1410 97.9 0.07 0.91
p xy
∅
z
(a) Nominal
p
Solid water
Detectors
Collimator
Water
Target volume
(b) Solid water insert
p
Range shifter
(c) 2.2; 5.2 mm shifter
p
Bone insert
(d) Inner; Cortical bone
Figure 4: Schematic of the experimental setups to assess the range verification performance (top view,
dimensions are in mm). Protons (red arrow) irradiate the water phantom (blue: water, light gray: walls),
where x0 =−174mm and ziso =−40 mm. The FOV coordinate system is defined in figure 3. The black
dash-dotted lines intersect at isocenter. The dashed red rectangle is the target volume (5.3×10×10
cm3). The prompt gamma-rays are collimated (gray) and measured with scintillation detectors (green).
(a) Reference case in water with no range error. (b) Solid water block (brown) covering half of the field.
(c) 2.2 mm or 5.2 mm water equivalent range shifter (brown) covering half of the field. (d) 5 mm thick
slab (orange) of inner or SB3 cortical bone inserted in the middle of the field.
4.2. Absolute range verification
To test the range verification with a clinically realistic pencil-beam field, we designed a
treatment plan to deliver a uniform dose of 0.9 Gy to a 5.3×10×10cm3 target in water, as
shown in figure 4a. The isocenter was located centrally in the target and the distance between
isocenter and the collimator front face was 200 mm (ziso =−40 mm). There was an air gap
of 100 mm between the collimator and the phantom, which would also be realistic when the
system is used clinically. The FOV center was at a depth of−x0 = 174mm mm in the phantom,
see figure 3.
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Figure 5: Visualization of the planning images and pencil-beam positions in the treatment plan,
superimposed with the modeled 6.1 MeV prompt gamma-ray emission density Nc=8,s=101,v,l=6,t=0γ /(1×
2× 2mm3) for the central spot of the distal layer, see equation (4). Relative to the field of view
(figure 3), the top view is at slice y= 0 mm, the beam perspective is at slice x = 31 mm, and the detector
perspective is at slice z =−40 mm (white cross-hair lines). The phantom setup corresponds to figure 4a,
placed at x0 =−174mm and ziso =−40 mm. The pencil-beam spot scanning pattern is overlaid in the
beam’s eye view, as red spots. The green cylinder (circle or rectangle in the projections) indicates a 10
mm merging radius and a 10 mm depth, enclosing spots from the two distal energy layers, as explained
in sections §2.10 and 3.8. The dashed blue rectangles represent the target region of the treatment plan.
The red lines mark the nominal ranges R80 of the pencil-beam energy layers (table 4).
The treatment plan was created using our in-house Astroid treatment planning system
(Kooy et al. 2010). The dose was delivered to the target volume with a total of 1410 pencil-
beams in eight energy layers, as described in table 4. The uniform dose region of the proton
pencil-beams extends between 15 cm and 20.3 cm depth. The lateral distance between two
neighboring pencil-beam spots in the distal energy layer is approximately 9 mm and the
separation between consecutive energy layers is about 8 mm. We used the standard clinical CT
conversion, assuming the phantom to consist of soft tissue. This means that the model has no
prior knowledge of the actual elemental composition, which is left as free parameter kst to be
fitted simultaneously to the absolute range error εs, see equation (11).
Figure 5 shows the pencil-beam scanning treatment plan and the prompt gamma-ray
emission for one of the pencil-beam spots. We also show the merging region that defines
the area in which we aggregate the measurement data for range verification, as discussed
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in sections §2.10 and 3.8. Altogether, including the lateral merging, the merging region
corresponding to spot s can be visualized as a cylinder of 10 mm radius and 10 mm depth,
enclosing typically a total of 14 pencil-beams, i.e. 7 from each layer.
The range verification performance was further assessed by introducing different
inhomogeneities in this setup, as shown in figure 4:
• Setup 4a is the reference case where no range error is expected.
• In setup 4b, a solid water block (Gammex RMI, Middleton WI) is inserted in half of
the water phantom at a depth of 125 mm. This setup is devoted to test the capability
of the prototype to accurately detect the absolute range independently of the elemental
composition of the irradiated tissue. Solid water has a stopping power close to that of
water (1.02 ratio), but a by-mass elemental composition of 67% C, 20% O and 8% H
(Hu¨nemohr et al. 2014), very different from that of water (89% O, 11% H). A shift of 1.7
mm of the end-of-range is expected for the pencil-beams of the distal energy layer going
through the solid water.
• Setup 4c includes a range shifter placed in front of the water phantom and covering half
of the field. We used range shifters with a water equivalent thickness of 2.2 and 5.2 mm.
• In setup 4d, a bone equivalent slab with a thickness of 5 mm of inner or SB3 cortical
bone (Gammex) is inserted into the water phantom, centered at a depth of 174 mm. The
expected shifts of the end-of-range are 0.5 mm for inner bone and 3.0 mm for cortical
bone.
The expected range shifts created by the Gammex materials were determined based on proton
stopping power measurements that we performed by measuring the shift in the Bragg peak
position in water when the materials are placed in the beam path. The stopping powers that
we measured are consistent with the measurements by Saito et al. (2017) and Hu¨nemohr et al.
(2014).
5. Results
5.1. Energy- and time-resolved histograms
An example of the acquired energy- and time-resolved prompt gamma-ray histogram and the
separation into the different components (2.9) is presented in figure 6. This histogram was
acquired during the cross section calibration experiment (section §4.1), in which a high dose
was delivered. It shows the excellent performance of the detectors and the data acquisition
system at a beam current of 2 nA. During the delivery of the distal layer, the count rate in
each detector was on the order of 106 events per second. Even under these conditions, an
energy resolution of 1.3% full width at half maximum was obtained at 6.1 MeV, allowing the
gamma-ray lines to be clearly resolved. A robust separation of the continuum and resolved
components can be observed. The background constitutes approximately half of the detected
gamma-rays, including sources such as the proton treatment head, phantom, couch, walls and
floor of the treatment room. There is also some production of neutron-induced gamma-rays in
the collimator, but most of these are re-absorbed internally.
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Figure 6: From left to right: measured 2D spectrum of the energy deposit over trigger time with
respect to the cyclotron radiofrequency; the neutron- and proton-continuum background estimated by
our algorithm; resolved neutron-induced and proton-induced lines. This measurement was performed
during the irradiation of a water phantom with 2 nA beam current. These spectra were measured by
detector row r = 1 during the cross section optimization experiment (section §3.9), where a high dose
was delivered. Piled-up or coincident events have been excluded.
5.2. Cross section optimization
The consistency of the re-optimized cross sections was verified by calculating the relative
deviation ∆lt = 〈1−σ elt/σˆ elt〉 between the optimized and our previous cross sections (Verburg
et al. 2014), averaged over the proton energy range from 0 MeV to 150 MeV. For the more
prominent prompt gamma-ray lines, the differences are ∆40 = 17%, ∆41 = 5%, and ∆61 = 12%.
5.3. Absolute range verification
In figure 7, the absolute range verification is shown for the experiments in which a dose of 0.9
Gy was delivered to a target in different phantom setups. These results were obtained for each
spot of the most distal energy layer, using a cylindrical merging region of 10 mm radius and 10
mm depth, as shown in figure 5. Note that the range errors are not calculated with respect to a
previous measurement, but with respect to the value predicted by the simulated model with
only the planning CT as prior information.
The experimental setups correspond to figure 4: featuring no range shifter (figure 4a),
a solid water insert in half of the field (figure 4b), a range shifter covering half of the field
upstream of the water phantom (figure 4c) and a bone insert slab within the phantom covering
the full field (figure 4d).
In figure 8, the determined oxygen and carbon concentrations are shown for two of the
experiments: the nominal case without range shifter (figure 4a) and the setup with a solid water
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(a) Nominal case, figure 4a.
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(b) Solid water insert on left, figure 4b.
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(c) 2.2 mm shifter on left, figure 4c.
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(d) 5.2 mm shifter on left, figure 4c.
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(e) Inner bone, figure 4d.
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(f) Cortical bone, figure 4d.
Figure 7: Range verification of the distal layer of a proton pencil-beam field delivering 0.9 Gy to a
5.3×10×10cm3 region. The Y and Z axis correspond to the y and z− ziso axes of figure 3. The proton
range error εs with respect to the model prediction is annotated within the colored circles. Shown are the
experiments without range shifter (a), with a solid water insert in the left half of the field (b), with a 2.2
mm (c) and 5.2 mm (d) range shifter covering the left half of the field, and with the inner (e) and SB3
cortical (f) bone inserts. Each spot contains information from a cylindrical merging region of 10 mm
depth and 10 mm radius (figure 5). The histograms show the range errors with a bin width of 0.4 mm,
in which a dashed black vertical line marks the theoretically introduced range shift. Where relevant, the
histograms are shown separately for the left (Z <−20 mm) and right (Z > 20 mm) parts of the field.
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(a) Nominal case with liquid water, see figure 4a.
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(b) Solid water insert on the left half of the field, see figure 4b.
Figure 8: Elemental composition determination for the same pencil-beam field as in figure 7. The
oxygen and carbon concentrations by mass ρst are shown in the left and right columns. The reference
case (a) is compared with the solid water insert in the left half of the field (b). Each spot contains
information from a cylindrical merging region of 10 mm depth and 10 mm radius.
insert in half of the field (figure 4b). The differences in elemental composition in the different
parts of the field can be clearly identified.
To determine the mean accuracy and the mean statistical precision of the range verification,
we repeated all of the above experiments 12 times. The results are listed in table 5. Averaging
all experiments, the mean systematic deviation in the determined range was 0.5 mm. The
mean statistical precision, determined by calculating the standard deviation of the repeat
measurements, was 1.1 mm at a 95% confidence level (2σ ) for the chosen merging radius of
10 mm and 10 mm depth. For the case of the solid water insert (figure 7b), we obtain a larger
statistical uncertainty (1.9 mm) in the left part of the field. This is in accordance with the lower
prompt gamma-ray yield of carbon with respect to oxygen targets (Verburg et al. 2014; Pinto
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Table 5: Determined range error and elemental concentrations for the pencil-beams irradiating the
different setups, averaged over the distal energy layer. The mean absolute range error and the mean
statistical precision (±2σ ) are listed. The range error ε refers to the difference between the measured
range of the pencil-beams and the model prediction based on the treatment plan. Where relevant, the
results are given separately for the left part of the field (Z <−20 mm) and the right part (Z > 20 mm).
The statistics were calculated based on 12 repeated measurements.
Setup Range error ε / mm ρ(16O) / g cm−3 ρ(12C) / g cm−3
Left Right Left Right Left Right
4a - Nominal −0.2±1.0 0.88±0.09 0.05±0.06
Expected 0.0 0.89 0.00
4b - Solid water −2.4±1.9 −0.5±1.0 0.17±0.05 0.88±0.10 0.76±0.08 0.03±0.05
Expected −1.7 0.0 0.20 0.89 0.67 0.00
4c - 2.2 mm shifter −1.9±1.1 −0.4±0.9 0.90±0.10 0.88±0.07 0.07±0.08 0.03±0.05
Expected −2.2 0.0 0.89 0.89 0.00 0.00
4c - 5.2 mm shifter −4.4±1.1 −0.4±0.9 0.88±0.09 0.88±0.07 0.07±0.08 0.02±0.05
Expected −5.2 0.0 0.89 0.89 0.00 0.00
4d - Inner bone −0.8±1.0 0.87±0.10 0.09±0.08
Expected −0.5 0.89 0.00
4d - Cortical bone −2.3±1.0 0.85±0.09 0.10±0.08
Expected −3.0 0.89 0.00
Range error
(a) 5.2 mm shifter on left half of field, see figure 7d. (b) Nominal case, see figure 7a.
Figure 9: Planning images superimposed with the reconstructed proton dose based on the measurements
of figure 7. The pencil-beams are simulated with the GPU based on the measured proton range. Axes
are in mm and correspond to the FOV definition (figure 3). The red dashed rectangle shows the target
region of 5.3 cm × 10 cm covered uniformly with 0.9 Gy. The image corresponds to slice y = 0 mm.
Isodose lines at 95%, 80%, 60%, 40% and 20% levels of the target dose are shown.
et al. 2015). The fitted elemental compositions are in agreement with the expected values in all
cases.
We also recalculated the dose distributions based on the range verification results. In
figure 9, the central slice y = 0 mm of the dose distribution in the water phantom is shown.
The setup with a 5.2 mm range shifter on the left part of the field (figure 7d) is compared to the
reference case (figure 7a). The underdosage in the distal part of the target volume (red dashed
rectangle) and the overdosage in the proximal region, that are introduced by the range shift,
can be observed.
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6. Discussion
Compared to our forerunner pre-clinical prototype with a single detector (Verburg et al. 2014),
we have further developed and scaled up our prompt gamma-ray spectroscopy technology to
achieve millimeter accuracy in proton range verification at a clinical beam current and dose.
Even under these challenging conditions, our system is uniquely able to perform energy- and
time-resolved prompt gamma-ray measurements that are normalized to absolute units, which
facilitates a direct comparison with nuclear reaction models. The statistical precision achieved
with this prototype outperforms previously published results from other prompt gamma-ray
imaging systems at clinical beam currents and doses, mainly because of the higher detector
throughput and efficiency.
Prompt gamma-ray spectroscopy has the advantage of incorporating an energy- and time-
resolved event analysis in addition to the spatial collimation. The range verification algorithm
is therefore able to reconstruct the proton range and the elemental composition of the target
tissue simultaneously. This reduces the bias in the retrieved proton range by minimizing the
uncertainty in the tissue composition, which can be different from the estimation based on
the planning CT scan due to conversion ambiguity. A potential future improvement is to
incorporate dual-energy CT for characterization of the elemental composition (Wohlfahrt et al.
2017). This would improve the accuracy of our model and it may be used to set constraints on
the elemental concentrations ρvt .
Our method considers many different nuclear reaction channels, which yields redundant
information for a reliable range verification. The model enables the prediction of the absolute
proton range with a bias below 1 millimeter only based on the planning CT, the measured
gamma-rays and fundamental physical principles. The simulation is based on established
Monte Carlo methods, tabulated nuclear cross sections, and an empirical calibration of the
unresolved proton continuum. This direct physical basis overcomes one of the main limitations
of range verification using positron emission tomography, where biological washout effects
need to be considered, which are difficult to model (Knopf et al. 2011).
The performance of our system is enhanced by the design of the collimator, which is set
up in such a way that the FOV is focused on the distal edge of the Bragg peak, where the
emitted prompt gamma-rays have a stronger correlation with the range of the beam than in the
entrance path. The slit opening is chosen as a compromise between systematic uncertainties
and statistical precision: a narrower collimator would increase the spatial resolution but impair
the collected statistics in detector row r = 0. The open slit configuration for the distal detector
row r = 1, as previously shown by Verburg et al. 2015, maximizes the number of collected
events at the end-of-range. In an actual patient, where the beam entrance surface might not be
flat and the tissue is not homogeneous, the proton ranges of the spots from the same energy
layer will not be at the same depth with respect to the collimator. Hence, having two detector
rows at different depths will be beneficial to enclose most of the proton stopping points within
the FOV.
The range errors that we introduced in this work were range undershoots. In the case
of a range overshoot, the statistical precision will be higher because of more gamma-rays
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reaching the detectors. Also, as expected from the prompt gamma-ray yields, the statistical
precision is higher in matter with a high 16O concentration as compared to matter with a high
12C concentration. This is advantageous for clinical range verification. The oxygen fraction in
a variety of tumor samples has been shown to range between 57% and 78% (Maughan et al.
1998). Brain tissue and soft tissue, which are often critical organs, are also rich in oxygen.
The aggregation of prompt gamma-ray measurements from proton pencil-beams within
a 10 mm lateral merging radius and a 10 mm depth is what we believe constitutes a good
trade-off between resolution and statistical precision. The data that we used for the range
verification of each distal spot correspond to the delivery of about 1.6× 109 protons and a
mean accumulated dose to the target volume of 1.6 cGy. In the case of single-field optimization
of the dose delivery, as was used in the experiments in this work, the large majority of the
protons stop very close the distal end of the target. Therefore, the verification of the range
of the distal proton energy layers is of main importance. Multi-field optimized treatment
plans created with robust optimization also deliver most dose to the distal layers, because the
delivery of additional dose outside the target volume is possible there to account for range
uncertainty. When prompt gamma-ray spectroscopy allows for a significant reduction of the
range uncertainty, intensity-modulated treatment plans may be designed with higher doses
being delivered to parts of the more proximal energy layers. In this situation, it will likely be
advantageous to use a spatially varying merging region to account for the local differences in
the delivered number of protons.
The prompt gamma-ray spectroscopy method is able to estimate the real composition,
as well as the magnitude of the range error, even if the delivered pencil-beam ranges are
quite different from the treatment plan. Several potential range errors are simulated and the
most likely one according to the match with the measurements is determined. It is however
possible that complex differences occur between the treatment planning and the delivery, for
example, if the heterogeneities in the beam path are very different as compared to the plan.
In this case, significant discrepancies between the model and the measurement data would
be observable, which might be more difficult to interpret as only a range error. This would
serve as an indication that the positioning of the patient has to be checked and that re-planning
may be necessary. When adaptive workflows based on a daily cone-beam CT become more
commonplace, this would be less of an issue.
For a smooth integration of our prototype in the clinical workflow during the first patient
study, we are developing a six-axis positioning robot and a laser alignment system. Our rotating
detector frame will be mounted on these actuators as shown in figure 10, which will enable
a fast, accurate and reproducible detector alignment with respect to the patient using several
alignment lasers. The robot itself will stand on a mobile platform.
The reconstructed proton range and dose will be superimposed on the patient CT to assess
for significant range deviations with respect to the treatment plan, as shown in figure 9a. As
emphasized by Verburg et al. (2014), the absolute range can be determined without prior
knowledge of the tissue composition already for the first treatment fraction, and further relative
range shifts can be detected for later fractions with high precision.
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Detection system
Positioning robot
Proton treatment head
Figure 10: Illustration of the gantry, proton treatment head, patient, top x-ray flat panel and our
prototype range verification system. The detector frame can rotate according to the gantry angle, and is
mounted on a positioning robot, consisting of six actuators. The robot stands on a platform on wheels
that is moved into the treatment room.
Once the robustness and accuracy of the prototype is demonstrated during actual
treatments, the prompt gamma-ray spectroscopy system could promote the correction of
range errors in upcoming treatment fractions with re-planning, thus improving the quality of
treatment and, potentially, the outcome. On a longer term, we envision real-time adaptation of
the range, the reduction of range margins, and novel treatment plan designs that take advantage
of the sharp distal gradient of the Bragg peak to maximize the sparing of organs-at-risks that
surround the target volume.
7. Conclusions
A full-scale clinical prototype system for proton range verification using prompt gamma-ray
spectroscopy was tested with phantoms at the pencil-beam scanning gantry treatment room of
the Francis H. Burr Proton Therapy Center. The developed electronics and calibration methods
performed well at a clinical beam current of 2 nA incident on the phantoms. A detailed
model of prompt gamma-ray emission and system response was developed, that enables the
reconstruction of both the proton range and the elemental composition of the irradiated matter
based on the measurements.
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The absolute range was determined for each pencil-beam spot of the distal energy layer
with a mean statistical precision of 1.1 mm at a 95% confidence level and a mean absolute
deviation of 0.5 mm, for a delivered dose of 0.9 Gy, and by aggregating data from pencil-beams
in a merging cylinder of 10 mm radius and 10 mm depth. Range errors that we introduced
were detected accurately even in the presence of large differences in the elemental composition
with respect to the assumptions based on the planning CT scan.
Our results show for the first time that proton range verification with 1 millimeter precision
is achievable in phantoms under clinically realistic conditions. An experiment with a ground-
truth anthropomorphic head phantom (Wohlfahrt et al. 2018) is planned as the final validation
prior to our upcoming clinical study, where we will test our prototype during the treatment of
patients with brain tumors.
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